Notice of Intent to issue a Sole Source Award to support development and validation of novel ARV detection methods.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), Division of HIV Prevention (DHP)/Laboratory Branch (LB), has issued a Notice of Intent to Issue a Sole Source Award to Emory University. This award aims to support the development and validation of novel Antiretroviral (ARV) detection methods by obtaining freshly collected, matched biological specimens. Responses from interested parties are due by June 2, 2026.
Scope of Work
Emory University will be responsible for collecting fresh, matched samples of whole blood and urine from individuals receiving ARVs for HIV treatment or prevention, as well as from individuals not receiving ARVs. These specimens must be delivered to CDC DHP Laboratory Branch staff within 24 hours of collection. The CDC will use these samples for analysis with research use only (RUO) assays that employ novel methods for measuring ARVs, assessing their consistency with LC-MS-MS and convenience for future development.
Contract & Timeline
- Type: Sole Source Firm Fixed Price Purchase Order (under FAR 12.102-1)
- NAICS: 541715 - Medical research and development laboratories or services
- Set-Aside: None (Sole Source Intent)
- Response Due: June 2, 2026, 5:00 PM ET
- Published: May 12, 2026
- Place of Performance: Atlanta, GA
Justification & Evaluation
The CDC intends to award this as a sole source to Emory University because it is identified as the only source capable of delivering freshly collected biological specimens within the required timeframe (a few hours) without compromising specimen integrity. There are no other companies or state-licensed medical clinics within a reasonable distance from the CDC that can provide these specific services. This notice is not a request for competitive quotations; however, all responses received within 15 days of issuance will be considered by the government solely for the purpose of determining whether to conduct a competitive procurement.
Additional Notes
Interested parties capable of providing these services should email their quotation/response to the contract specialist by the due date. A determination by the government not to complete this proposed contract based on responses is solely at the government's discretion.
- Primary Contact: Eugene L. Gutierrez Jr. (zvm0@cdc.gov)